Company Filing History:
1 out of 166 
1 out of 1,524 
Years Active: 2003
Title: François Brugger: Innovator in Pharmaceutically Active Aerosols
Introduction
François Brugger, a notable inventor based in Waltenheim, France, has made significant contributions to the field of pharmaceutical aerosols. With a total of two patents to his name, Brugger's innovations focus on enhanced methods for storing and administering pharmaceutically active substances.
Latest Patents
Brugger's latest patent revolves around surface-active preparations specifically designed for aerosol containers. His invention features an innovative aerosol container for pharmaceutically active aerosols intended for precise administration in predetermined amounts. The design includes a metering valve with a metering chamber and valve stem, facilitating a controlled release of the aerosol. The container also accommodates alternative propellant gases free of fluorochlorohydrocarbons, ensuring a safer and more environmentally friendly option. Additionally, the inner wall of the container is protected with a specialized plastics coating, ensuring product integrity and reliability during use.
Career Highlights
Throughout his career, François Brugger has worked with leading companies in the pharmaceutical and chemical industries. He has been associated with Novartis Corporation and Ciba Specialty Chemicals Corporation, where he honed his skills in research and development to create innovative solutions in the realm of aerosols.
Collaborations
Brugger has collaborated with talented professionals such as Angelika Stampf and Marcel Schnyder, contributing to a dynamic exchange of ideas and expertise. These partnerships have been instrumental in driving his inventive endeavors and expanding the scope of his work in aerosol technology.
Conclusion
François Brugger's innovative spirit and dedication to developing advanced aerosol technologies have positioned him as a noteworthy inventor in the pharmaceutical field. His patents not only reflect his ingenuity but also contribute significantly to the improvement of drug delivery systems, ensuring greater accessibility and efficacy for patients worldwide.